Background: Renal osteodystrophy is a common complication of end-stage renal disease (ESRD) and is a major cause of morbidity in patients with ESRD. High serum levels of phosphorus, calcium and parathyroid hormone are associated with the development of ...
Freemont, A. J.; id_orcid +2 more
core +4 more sources
BACKGROUND: Hyperphosphatemia is a common complication in end-stage renal disease (ESRD) patients. Reducing the serum phosphate level is crucial in management of ESRD.
최훈영, 이호영
core +1 more source
Lanthanum Carbonate - A New Phosphate Binding Drug in Advanced Renal Failure
Background: Lanthanum (La) is considered to be a non-essential element. La has been used for several decades in China to improve yield in plant production and has also been shown to have significant performance enhancing effects in feeding trials on ...
Anne-Lise Bjorke-Monsen, Jan Aaseth
core +1 more source
A Literature Review of Modelling and Experimental Studies of Water Treatment by Adsorption Processes on Nanomaterials. [PDF]
Ibrahim Q, Creedon L, Gharbia S.
europepmc +1 more source
Superparamagnetic Spinel-Ferrite Nano-Adsorbents Adapted for Hg2+, Dy3+, Tb3+ Removal/Recycling: Synthesis, Characterization, and Assessment of Toxicity. [PDF]
Allwin Mabes Raj AFP +8 more
europepmc +1 more source
Adsorptive, kinetics and regeneration studies of fluoride removal from water using zirconium-based metal organic frameworks. [PDF]
Tan TL +3 more
europepmc +1 more source
Molten-Salt Synthesis of Complex Metal Oxide Nanoparticles. [PDF]
Zuniga JP, Abdou M, Gupta SK, Mao Y.
europepmc +1 more source
Study on the Process and Mechanism of Preparing Lanthanum Carbonate from Rare Earth Chloride Solution. [PDF]
Xu B +5 more
europepmc +1 more source
Controlled Coprecipitation of Amorphous Cerium-Based Carbonates with Suitable Morphology as Precursors of Ceramic Electrolytes for IT-SOFCs. [PDF]
Accardo G +4 more
europepmc +1 more source
Uptake and Binding of At-211 Into K- and Cs-Derivatives of Alpha-Zirconium Phosphate Nanoplatelets for Use as a Targeted Alpha Therapy Delivery Platform. [PDF]
Madhushan BDI +10 more
europepmc +1 more source

